Status:
COMPLETED
Pharmacokinetic Properties of Various Modified Release Tablet Formulations of Lu AF11167
Lead Sponsor:
H. Lundbeck A/S
Conditions:
Schizophrenia
Eligibility:
All Genders
18-45 years
Phase:
PHASE1
Brief Summary
The purpose of this study is to investigate the pharmacokinetic (PK) properties of various modified release tablet formulations of Lu AF11167 (Part A) and to investigate the pharmacokinetic (PK) prope...
Eligibility Criteria
Inclusion
- Inclusion Criteria:
- Healthy men and women ≥18 and ≤45 years of age with a body mass index (BMI) of \>18.5 and \<30.0 kg/m2.
- Women of child-bearing potential will have a confirmed non-pregnant and non-lactating status.
- Other pre-defined inclusion and exclusion criteria may apply.
Exclusion
Key Trial Info
Start Date :
August 1 2014
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
Estimated Enrollment :
28 Patients enrolled
Trial Details
Trial ID
NCT02260830
Start Date
August 1 2014
Last Update
March 6 2015
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Quotient Clinical
Nottingham, United Kingdom